Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Konstantin Penkov | Researchclopedia

Back to researchers

Konstantin Penkov

City Clinical Hospital No 31

53

Works

4,189

Citations

18

h-index

20

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Renal cell carcinoma treatment Lung Cancer Research Studies

Affiliations

Russian Railways2020–2021

Saint-Petersburg Medico-Social Institute2018–2022

Institute of Oncology NN Petrov2012–2012

City Clinical Hospital No 312024–2026

Euromedic2019–2025

Top Works

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Robert J. Motzer,Konstantin Penkov,et al.

20192,505 citations

Lung Cancer Treatments and Mutations

Prostate Cancer Treatment and Research

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

Robert J. Motzer,Paul B. Robbins,et al.

2020507 citations

Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study

Fiona Blackhall,Kevin Jao,et al.

2021244 citations

Biomarker analyses from JAVELIN Renal 101: Avelumab + axitinib (A+Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).

Toni K. Choueiri,Laurence Albigès,et al.

201999 citations

Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study

Lauren A. Byers,Dmitry Bentsion,et al.

202173 citations

Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma

John B.A.G. Haanen,James Larkin,et al.

202355 citations

Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations

Alessandra Bearz,Jean‐François Martini,et al.

202348 citations

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

Toni K. Choueiri,Konstantin Penkov,et al.

202440 citations

JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC)

Robert J. Motzer,Konstantin Penkov,et al.

201834 citations